Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided immunology for decades. The research found that when cancer cells shut down a key immune-recognition molecule called MHC I—a common trick used to hide from “killer” T cells—they can actually become more vulnerable to attack by a different group of immune cells known as CD4+ “helper” T cells.
Trending
- Boy whose cancer returned two weeks after remission gets new hope from trial
- CFTR-driven immune microenvironment reprogramming synergizes with anti-PD-L1 antibody in hepatocellular carcinoma
- 74 Real-World Study Characterizing Patient Characteristics, Treatments, and Unmet Need in IO-Ineligible Patients With Metastatic Triple-Negative Breast Cancer
- Is Any Alcohol Good for You? Health Risks of Alcohol| U.S. News
- Tisa-Cel Yields Enduring Remissions in Younger High-Risk B-ALL Population
- Fixed-Duration Epcoritamab Combo Shows Superiority in Follicular Lymphoma
- Blood Cancer United buys drug stockpile for compassionate use
- IL11 modulates MMP12 expression and cancer cell metastasis via IL11RA/IL6ST-PI3K/Akt/NF-κB pathway in lung cancer

